Logo image of BNTX

BIONTECH SE-ADR (BNTX) Stock News

NASDAQ:BNTX - Nasdaq - US09075V1026 - ADR - Currency: USD

104.94  +2.51 (+2.45%)

After market: 104.94 0 (0%)

BNTX Latest News, Press Relases and Analysis

News Image
3 days ago - The Motley Fool

Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.

There's no need to track down complicated and obscure businesses. Some of the market's best income-producing stocks are hiding in plain sight.

Mentions: O PFE WMT FDX ...

News Image
4 days ago - Zacks Investment Research

Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales

PFE beats first-quarter estimates for earnings but misses the same for sales. It maintains 2025 guidance.

Mentions: PFE BMY JNJ

News Image
5 days ago - Benzinga

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine has created uncertainty across the vaccine industry, potentially affecting other manufacturers.

Mentions: NVAX PFE MRNA

News Image
5 days ago - Benzinga

Why Is Summit Therapeutics Stock Trading Higher On Monday?

Summit Therapeutics highlights China approval of Akeso's ivonescimab for NSCLC, with enrollment ongoing for Phase 3 HARMONi-7 trial.

Mentions: MRK SMMT

News Image
7 days ago - Yahoo Finance

Akeso survival data for ivonescimab misses expectations, STAT says

While Akeso (AKESF) and Summit Therapeutics’ (SMMT) ivonescimab, a rival to Merck’s (MRK) Keytruda, won approval in China this week, the data on patient survival did not meet analyst expectations, Jonathan Wosen of STAT reports. In its submission to regulators, Akeso included data on patient survival, disclosing that an interim analysis following 157 patient deaths found that participants on ivonescimab had a roughly 22% reduced risk of death, with a hazard ratio of 0.784, a company spokesperson

Mentions: SMMT MRK SAIA XPO ...

News Image
8 days ago - Yahoo Finance

4 Pipeline Stocks to Buy With $1,000 and Hold Forever

Pipeline companies remain well positioned despite the current disruption in the energy markets. At the same time, demand for natural gas is growing. This is coming from the increased power consumption stemming from artificial intelligence (AI), as well as from export demand from Mexico and for LNG (liquified natural gas) to Asia and Europe.

Mentions: ET EPD KMI WMB ...

News Image
10 days ago - BioNTech SE

BioNTech präsentiert auf der AACR-Jahrestagung 2025 klinische und präklinische Daten zu mRNA- und Immunonkologie-Fokus-Programmen

MAINZ, Deutschland, 24. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der diesjährigen Jahrestagung...

News Image
10 days ago - BioNTech SE

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025

MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified...

News Image
10 days ago - Investor's Business Daily

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech is on the rise after Summit Therapeutics unveiled promising results for its PD-1- and VEGF-blocking drug.

Mentions: SMMT MRK

News Image
11 days ago - Yahoo Finance

This Company's Co-CEOs Just Bought More Shares. Should You?

Nobody has more information about a company than its insiders, especially its executive management team. On April 8, Summit Therapeutics' co-CEOs, Robert Duggan and Maky Zanganeh, each exercised warrants, financial instruments that grant their holders the right (but not the obligation) to acquire a company's shares at a predetermined price before a particular date. Do Summit Therapeutics' prospects -- beyond this recent development -- justify investing in the stock today?

Mentions: SMMT MRK DHI CMG ...

News Image
12 days ago - BioNTech SE

BioNTech veröffentlicht am 5. Mai 2025 Ergebnisse für das erste Quartal 2025 und informiert über operativen Fortschritt

MAINZ, Deutschland, 22. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird am Montag, den 5. Mai 2025, die...

News Image
12 days ago - BioNTech SE

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

MAINZ, Germany, April 22, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the...

News Image
23 days ago - Stocktwits

Novavax Retail Traders Rally In Defense After RFK Jr.'s COVID-19 Vaccine Skepticism Sends Stock Tumbling

Kennedy singled out the Novavax COVID-19 shot's single-antigen composition as the reason behind the delay in granting full approval.

Mentions: NVAX PFE MRNA CBS

News Image
23 days ago - Investor's Business Daily

Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.

From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care.

Mentions: RY RY.CA MRNA CYBN ...

News Image
a month ago - Yahoo Finance

Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where BioNTech SE (NASDAQ:BNTX) stands against other best German stocks to buy according to hedge funds. Germany’s economy is facing continued weakness. According to a report published by […]

News Image
a month ago - Yahoo Finance

Is Deutsche Bank Aktiengesellschaft (DB) the Best German Stock to Buy According to Hedge Funds?

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Deutsche Bank Aktiengesellschaft (NYSE:DB) stands against other best German stocks to buy according to hedge funds. Germany’s economy is facing continued weakness. According to a report published […]

Mentions: DB DZZ ROLR PM ...

News Image
a month ago - Yahoo Finance

Is Quanta Services Inc. (PWR) the Best Engineering Stock to Invest in Now?

We recently published a list of 11 Best Engineering Stocks to Invest in Now. In this article, we are going to take a look at where Quanta Services Inc. (NYSE:PWR) stands against other best engineering stocks to invest in now. The global engineering services market was valued at $3.26 trillion in 2023, as reported by […]

Mentions: PWR STX OSUR SRAD ...

News Image
a month ago - Bloomberg

Vaccine Makers Plunge After FDA Biologics Head Marks Steps Down

Moderna Inc. shares plunged after the resignation of Peter Marks, a top regulator at the US Food and Drug Administration who had long overseen approvals of vaccines and other biological drugs.

Mentions: MRNA NVAX SRPT

News Image
2 months ago - Stocktwits

BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic

For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros.

Mentions: PFE IBB FNDF

News Image
2 months ago - BioNTech SE

BioNTech veröffentlicht Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 sowie Informationen zur Geschäftsentwicklung

Onkologie-Pipeline weiterentwickelt mit mehr als 20 aktiven klinischen Phase-2- und Phase-3-Studien mit strategischem Fokus auf zwei tumorübergreifende...

News Image
2 months ago - BioNTech SE

BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan-tumor programs:...